Pathomechanisms in central serous chorioretinopathy: A recent update
Arman Zarnegar1, Joshua Ong1, Tejaswini Matsyaraja2
1Department of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
International Journal of Retina and Vitreous
|January 20, 2023
Summary
Central serous chorioretinopathy (CSCR) involves choroidal dysfunction. Current theories suggest pachychoroid disease spectrum and venous congestion contribute to CSCR, impacting patient outcomes.
Area of Science:
- Ophthalmology
- Choroidal Diseases
Background:
- Central serous chorioretinopathy (CSCR) is a significant cause of vision impairment.
- The precise pathological mechanisms underlying CSCR remain incompletely understood.
- Current research highlights choroidal dysfunction as a key factor in CSCR pathogenesis.
Purpose of the Study:
- To explore the pathophysiological underpinnings of central serous chorioretinopathy (CSCR).
- To review current theories on CSCR, focusing on choroidal dysfunction and the pachychoroid disease spectrum.
Main Methods:
- Review of current theories and recent studies on CSCR.
- Examination of potential causes of choroidal hyperpermeability and leakage.
- Discussion of factors including venous congestion, inflammation, and systemic influences.
Main Results:
- The pachychoroid disease spectrum is central to CSCR theories.
- Choroidal hyperpermeability may result from venous congestion, inflammation, mineralocorticoid activation, and systemic factors.
- Scleral thickness and vortex vein drainage are proposed contributors to venous congestion.
Conclusions:
- Understanding CSCR's molecular and physiological mechanisms is crucial.
- Improved diagnosis and treatment strategies are needed for better patient outcomes.
More Related Videos
10:24Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report
Published on: February 12, 2018
10.2K
10:14Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
Published on: May 26, 2023
3.4K
